Korean J Ophthalmol.  2016 Apr;30(2):127-133. 10.3341/kjo.2016.30.2.127.

Clinical Characteristics of Juvenile-onset Open Angle Glaucoma

• Kwun Y
• Lee EJ
• Han JC
• Kee C

• KMID: 2160463
• DOI: http://doi.org/10.3341/kjo.2016.30.2.127

Abstract

PURPOSE
To demonstrate the clinical characteristics of juvenile-onset open angle glaucoma (JOAG) and to evaluate the prognostic factors for visual field (VF) progression in eyes with JOAG.
METHODS
The medical records of 125 eyes of 72 patients with JOAG were analyzed retrospectively. At least four reliable VF tests were required to determine the VF progression, and the progression was defined using the modified Anderson criteria. Comparisons in clinical manifestations among groups were performed using independent t-test, and generalized estimating equations were also conducted.
RESULTS
The mean follow-up duration was 94.4 ± 50.5 months. Patients with JOAG showed a male preponderance (64 %), myopia (−4.99 ± 4.01 diopters) and a severe elevation of intraocular pressure (35.6 ± 10.8 mmHg). Forty-two JOAG patients (58 %) had complained of symptoms associated with vision and pain; however, one-third presented with no definite symptoms. Fifty-seven patients were diagnosed with JOAG in both eyes, and they were significantly older (p = 0.039) and had a greater family history (p = 0.035) than patients with unilateral JOAG. The progression group exhibited a significantly higher intraocular pressure at the last visit (p = 0.023) than the non-progression group.
CONCLUSIONS
Because patients with considerable JOAG had no definite symptoms, periodic eye examinations are needed. To prevent the VF's progression, JOAG patients may require more careful management of intraocular pressure.

Keyword

Family history; Juvenile-onset open angle glaucoma; Visual field progression

MeSH Terms

Follow-Up Studies
Glaucoma, Open-Angle*
Humans
Intraocular Pressure
Male
Medical Records
Myopia
Retrospective Studies
Visual Fields

Reference

1. Dielemans I, Vingerling JR, Wolfs RC, et al. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands: the Rotterdam Study. Ophthalmology. 1994; 101:1851–1855.

2. Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004; 111:1641–1648.

3. Wang YX, Xu L, Yang H, Jonas JB. Prevalence of glaucoma in North China: the Beijing Eye Study. Am J Ophthalmol. 2010; 150:917–924.

4. Johnson AT, Drack AV, Kwitek AE, et al. Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma. Ophthalmology. 1993; 100:524–529.

5. Wiggs JL, Haines JL, Paglinauan C, et al. Genetic linkage of autosomal dominant juvenile glaucoma to 1q21-q31 in three affected pedigrees. Genomics. 1994; 21:299–303.

6. Aponte EP, Diehl N, Mohney BG. Incidence and clinical characteristics of childhood glaucoma: a population-based study. Arch Ophthalmol. 2010; 128:478–482.

7. Fung DS, Roensch MA, Kooner KS, et al. Epidemiology and characteristics of childhood glaucoma: results from the Dallas Glaucoma Registry. Clin Ophthalmol. 2013; 7:1739–1746.

8. Lotufo D, Ritch R, Szmyd L Jr, Burris JE. Juvenile glaucoma, race, and refraction. JAMA. 1989; 261:249–252.

9. Park SC, Kee C. Large diurnal variation of intraocular pressure despite maximal medical treatment in juvenile open angle glaucoma. J Glaucoma. 2007; 16:164–168.

10. Rahi JS, Cumberland PM, Peckham CS. Visual impairment and vision-related quality of life in working-age adults: findings in the 1958 British birth cohort. Ophthalmology. 2009; 116:270–274.

11. Anderson DR, Patella VM, editors. Automated static perimetry. 2nd ed. St. Louis: Mosby;1999. p. 76–159. p. 204–211.

12. Goldwyn R, Waltman SR, Becker B. Primary open-angle glaucoma in adolescents and young adults. Arch Ophthalmol. 1970; 84:579–582.

13. Perkins ES. Glaucoma in the younger age groups. Arch Ophthalmol. 1960; 64:882–891.

14. Gupta V, Ov M, Rao A, et al. Long-term structural and functional outcomes of therapy in juvenile-onset primary open-angle glaucoma: a five-year follow-up. Ophthalmologica. 2012; 228:19–25.

15. Fontana L, Armas R, Garway-Heath DF, et al. Clinical factors influencing the visual prognosis of the fellow eyes of normal tension glaucoma patients with unilateral field loss. Br J Ophthalmol. 1999; 83:1002–1005.

16. Ernest PJ, Schouten JS, Beckers HJ, et al. An evidence-based review of prognostic factors for glaucomatous visual field progression. Ophthalmology. 2013; 120:512–519.

17. Wu J, Hewitt AW, Green CM, et al. Disease severity of familial glaucoma compared with sporadic glaucoma. Arch Ophthalmol. 2006; 124:950–954.

18. Souzeau E, Burdon KP, Dubowsky A, et al. Higher prevalence of myocilin mutations in advanced glaucoma in comparison with less advanced disease in an Australasian disease registry. Ophthalmology. 2013; 120:1135–1143.

19. Aldred MA, Baumber L, Hill A, et al. Low prevalence of MYOC mutations in UK primary open-angle glaucoma patients limits the utility of genetic testing. Hum Genet. 2004; 115:428–431.

20. Fingert JH, Heon E, Liebmann JM, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet. 1999; 8:899–905.

21. Sripriya S, Uthra S, Sangeetha R, et al. Low frequency of myocilin mutations in Indian primary open-angle glaucoma patients. Clin Genet. 2004; 65:333–337.

22. Shimizu S, Lichter PR, Johnson AT, et al. Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma. Am J Ophthalmol. 2000; 130:165–177.

23. Yen YC, Yang JJ, Chou MC, Li SY. Identification of mutations in the myocilin (MYOC) gene in Taiwanese patients with juvenile-onset open-angle glaucoma. Mol Vis. 2007; 13:1627–1634.